Radiofrequency ablation for Barrett’s oesophagus

Status
Ongoing
Project acroniem
BE-RFA
Introduction
Barrett’s oesophagus is a condition in which changes occur in the mucosal cells lining the lower portion of the oesophagus. This condition can be associated with abnormal formation and growth of oesophageal tissue and eventually lead to oesophageal cancer. Patients diagnosed with Barrett’s oesophagus may be treated with Radiofrequency Ablation (RFA). This is a technique in which heat is applied to the superficial layer of the oesophageal wall for a short period of time, causing the diseased tissue to die.

Objective
In this registration project, data on RFA treatments in patients with Barrett’s oesophagus are recorded. Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV) (National Institute for Health and Disability Insurance)The data are registered online by hospitals or similar establishments approved to perform such treatments and is a requirement for financial reimbursement from the Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV) (National Institute for Health and Disability Insurance). The project database contains RFA data for all patientIn this registration project, data on RFA treatments in patients with Barrett’s oesophagus are recorded. Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV) (National Institute for Health and Disability Insurance)The data are registered online by hospitals or similar establishments approved to perform such treatments and is a requirement for financial reimbursement from the Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV) (National Institute for Health and Disability Insurance). The project database contains RFA data for all patients with Barrett’s oesophagus who have undergone one or more RFA treatments in approved hospital establishments since 1 April 2016.

Financial support and partners
This registration project is run in collaboration with the RIZIV.

Contact
For more information about this registration project, contact BERFA@kankerregister.org.